Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2002-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.301.2.720PMID 11961078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.

  2002cited by this paper
• Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts

  2000influential reference
• Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors.

  2000cited by this paper
• CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.

  1999cited by this paper
• Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.

  1999cited by this paper
• Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.

  1999cited by this paper
• Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.

  1999cited by this paper
• M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.

  1998cited by this paper
• The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists

  1998cited by this paper
• ALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORS

  1998cited by this paper
• Allosteric modulators of ligand binding to muscarinic acetylcholine receptors

  1998cited by this paper
• Allosteric binding sites on muscarinic receptors

  1997cited by this paper
• Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor.

  1997cited by this paper
• Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.

  1997influential reference
• Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.

  1997cited by this paper
• Quantitation of allosteric interactions.

  1996cited by this paper
• KOSTENIS AND MOHR REPLY : COMPOSITE ACTION OF ALLOSTERIC MODULATORS ON LIGAND BINDING

  1996cited by this paper
• Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

  1996cited by this paper
• Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.

  1996cited by this paper
• Constitutive activity of the M1–M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists

  1995cited by this paper
• Coupling of muscarinic m1, m2 and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins.

  1995cited by this paper
• Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.

  1995cited by this paper
• Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes.

  1992influential reference
• Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.

  1991cited by this paper
• Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.

  1991cited by this paper
• Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.

  1990cited by this paper
• Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.

  1990cited by this paper
• Characterization of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl ammonium bromide).

  1989cited by this paper
• Calculating receptor number from binding experiments using same compound as radioligand and competitor.

  1989cited by this paper
• Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

  1988cited by this paper
• Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.

  1988cited by this paper
• Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.

  1988cited by this paper
• Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.

  1988influential reference
• Modification of the binding properties of muscarinic receptors by gallamine.

  1983cited by this paper
• THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS

  1976influential reference
• Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide.

  1975influential reference
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds.

  1969influential reference

• SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor

  2024cites this paper
• Quantifying GPCR allostery and biased signaling

  2020cites this paper
• Allosteric Modulation of Muscarinic Receptors

  2016cites this paper
• Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation

  2016cites this paper
• RGS4 regulates partial agonism of the M2 muscarinic receptor-activated K+ currents

  2014cites this paper
• What ligand-gated ion channels can tell us about the allosteric regulation of G protein-coupled receptors.

  2013cites this paper
• Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors*

  2012cites this paper
• DFT calculation of four new potential agents muscarinic of bispyridinium type: structure, synthesis, biological activity, hydration, and relations with the potents W84 and DUO-3O

  2011cites this paper
• Structure-function studies of M4 muscarinic acetylcholine receptor allosteric modulation

  2011cites this paper
• Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias*

  2010cites this paper
• Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities

  2010cites this paper
• The Emergence of Allosteric Modulators for G Protein‐Coupled Receptors

  2010cites this paper
• Convergent, short synthesis of the muscarinic superagonist iperoxo

  2010cites this paper
• Rational design of dualsteric GPCR ligands: quests and promise

  2010cites this paper
• The Evolving Pharmacology of GPCRs

  2010cites this paper
• Signaling Diversity Mediated by Muscarinic Acetylcholine Receptor Subtypes and Evidence for Functional Selectivity

  2009cites this paper
• An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators

  2009cites this paper
• Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000

  2008cites this paper
• Allosteric interactions at the M3 muscarinic acetylcholine receptor

  2008cites this paper
• Two-State Models and the Analysis of the Allosteric Effect of Gallamine at the M2 Muscarinic Receptor

  2008influential citation
• Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.

  2007cites this paper
• Allosteric Modulation of Muscarinic Acetylcholine Receptors

  2007cites this paper
• PSNCBAM‐1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats

  2007cites this paper
• Allosteric Small Molecules Unveil a Role of an Extracellular E2/Transmembrane Helix 7 Junction for G Protein-coupled Receptor Activation*

  2007cites this paper
• Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors

  2007cites this paper
• Structure-Function Studies of Allosteric Agonism at M 2 Muscarinic Acetylcholine Receptors

  2007cites this paper
• Allosteric modulation of G protein-coupled receptors.

  2007cites this paper
• Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.

  2006cites this paper
• Allosteric and orthosteric binding modes of two nonpeptide human gonadotropin-releasing hormone receptor antagonists.

  2006cites this paper
• Muscarinic Receptors: Targeting Allosteric Modulation by the Development and Application of the Radiolabeled Allosteric Agent [3H]dimethyl-W84

  2006cites this paper
• Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity

  2006cites this paper
• Allosterism at muscarinic receptors: ligands and mechanisms.

  2005cites this paper
• Regulation of M2 Muscarinic Acetylcholine Receptor Expression and Signaling by Prolonged Exposure to Allosteric Modulators

  2005cites this paper
• Allosteric Modulation of the Cannabinoid CB1 Receptor

  2005cites this paper
• Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.

  2005cites this paper
• Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist

  2005cites this paper
• G-protein-coupled receptor allosterism: the promise and the problem(s).

  2004cites this paper
• Allosteric modulation of G protein-coupled receptors.

  2004cites this paper
• Determination of allosteric interactions using radioligand-binding techniques.

  2004cites this paper
• Allosteric modulation of G-protein coupled receptors.

  2004cites this paper
• Structure/activity relationships of M2 muscarinic allosteric modulators.

  2003cites this paper
• Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.

  2003cites this paper
• Cooperative Interactions at M2 Muscarinic Acetylcholine Receptors: Structure/Activity Relationships in Stepwise Shortened Bispyridinium- and Bis(Ammonio)Alkane-Type Allosteric Modulators

  2003cites this paper
• The [35S]GTPgammaS binding assay: approaches and applications in pharmacology.

  2003cites this paper
• Allosteric modulators of G-protein-coupled receptors.

  2003cites this paper
• The [35S]GTPγS binding assay: approaches and applications in pharmacology

  2003cites this paper
• Allosteric activation of plasma membrane receptors--physiological implications and structural origins.

  2003cites this paper